分子モーターの回転運動は,がん細胞を殺し,細胞カルシウムシグナル伝達を誘導する能力に影響する
Dallin Arnold1, Bowen Li1, Jacob L Beckham1
1Department of Chemistry, Rice University, 6100 Main Street, Houston, Texas 77005, United States.
Journal of the American Chemical Society
|June 17, 2025
まとめ
合成分子モーター (MM) は細胞に内部の力を与えます 異なる機能群でMMを修正すると,より小さなグループは回転を促進し,効果的な細胞死とカルシウムシグナル伝達につながります.
科学分野:
- 細胞メカニズム
- 合成生物学
- バイオ物理学
背景:
- 化学薬品は 細胞を操作するための 伝統的な道具です
- 細胞のプロセスには 機械的な力が不可欠です
- 合成分子モーター (MM) は,内部力適用を提供します.
研究 の 目的:
- 構造と機能の関係を調べる
- MM機能群が生物学的結果にどのように影響するかを決定する.
- 細胞死とカルシウムシグナル伝達のためのMMを探求する.
主な方法:
- 異なる機能群 (メチル,イソプロピル,ターチルブチル,フェニル) を有する4つのMMを合成した.
- 回転速度の計算に密度関数理論 (DFT) を利用した.
- 細胞破壊とカルシウムシグナル伝達におけるMMの有効性を評価した.
主要な成果:
- DFTの計算は,置換物のサイズに影響された回転率を予測した.
- メチル化されたMMは最速の回転を示した.
- メチル化MMは細胞死とカルシウムシグナル伝達に最も効果的でした.
結論:
- MMは単方向の回転によって 細胞環境に影響を与えます
- MMsからの内部的な力によって 制御可能な細胞活動が誘発されます
- 生物学的応用において,MMの設計,特に機能群は極めて重要です.
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Destabilization of Microtubules
2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Anaphase A and B
4.2K
Microtubules form through the end-to-end polymerization of tubulin heterodimers. Kinetochore microtubules originate from the spindle poles, and their plus-ends connect with the kinetochores on sister-chromatids. Ndc80 protein complexes, present on the kinetochore, form low-affinity links with the plus end of these kinetochore microtubules.
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
4.2K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K


